This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


trusted source


Video: What is multiple myeloma?

Video: What is multiple myeloma?
Credit: Mayo Clinic News Network

Multiple myeloma is a relatively uncommon form of blood cancer that affects less than 1% of the U.S. population, according the American Cancer Society.

March is Myeloma Awareness Month. People younger than 45 rarely get the disease, and it occurs more in older men than women. And your risk is doubled if you're African American.

"Multiple is an incurable blood cancer that produces a lot of proteins that can cause damage to various organs, particularly the bones as well as the kidney," says Dr. Rahma Warsame, a Mayo Clinic hematologist.

Symptoms vary but can include fatigue, bone pain, anemia and frequent infections. While it's not clear what causes multiple myeloma, doctors know that it begins with an abnormal plasma cell in your bone marrow which produces too much protein inappropriately and multiplies rapidly.

The disease almost always starts as a relatively benign condition called monoclonal gammopathy of undetermined significance, or MGUS.

"Much like a colon polyp is a premalignant condition, or that people have Pap smears for , MGUS is a premalignant condition. But it's only found in blood. It's when you find a little bit of excess protein that's in the blood. And this is something that indicates that you have the potential to become a multiple myeloma patient," says Dr. Warsame.

Credit: Mayo Clinic News Network

Like many other cancers, the disease can be treated with medication, chemotherapy, radiation and even transplant.

"I want all myeloma patients to know that the treatments are improving. The quality of life is improving. I've seen it in my own lifetime, the significant improvements in survival," says Dr. Warsame.

Provided by Mayo Clinic
Citation: Video: What is multiple myeloma? (2023, March 13) retrieved 24 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Patients with blood cancer precursor at risk of developing cancer even after 30 years


Feedback to editors